Event: | Lunch Symposium 4 by Roche |
Venue: | Manhattan Hall I |
Tocpic: | Time for chANGe: Integrating Faricimab Into First Line Therapy for PCV & DME |
Chair(s): | Dr Tara Mary George, Consultant Ophthalmologist and Medical Retina & Uveitis Specialist - Sunway Medical Centre, Selangor |
Time | Presentation Title | Speakers |
---|---|---|
1300 | Welcome and Introduction Faticimab Landscape |
Dr Tara Mary George, Consultant Ophthalmologist and Medical Retina & Uveitis Specialist - Sunway Medical Centre, Selangor |
1305 | Achieving Polyp Regression and Drying in PCV with Faricimab | Assoc Prof Dr Voraporn Chaikitmongkol, Consultant Vitreoretinal Surgeon and Medical Retina Specialist - Chiang Mai University Hospital, Thailand |
1315 | The Real-World Impact of Faricimab on Clinic Capacity | Dr. Rajasudha Sawri Rajan, Consultant Medical Retina & Uveitis Specialist - Hospital Shah Alam, Selangor |
1325 | Impact of Dual Pathway Inhibition on DME Biomarkers | Dr Tara Mary George, Consultant Ophthalmologist and Medical Retina & Uveitis Specialist - Sunway Medical Centre, Selangor |
1335 | The Real-World Experience of Faricimab in DME | Dr. Barkeh Hanim Binti Jumaat, Consultant Ophthalmologist and Vitreoretinal Surgeon - International Specialist Eye Centre (ISEC), Kuala Lumpur |
1345 | Duscussion, Q&A |
|
1400 | End |